Collection: Central Nervous System

At helcima, we are dedicated to advancing the field of neurology and psychiatry through our innovative portfolio of therapies and solutions for the Central Nervous System (CNS). With a deep understanding of neurological and psychiatric disorders, we strive to provide effective treatments that improve patient outcomes and enhance quality of life.

Our CNS portfolio offers a comprehensive range of medications, devices, and interventions designed to address the diverse needs of patients with conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, depression, and schizophrenia. From novel neuropharmaceuticals to advanced neurostimulation devices and cognitive rehabilitation programs, we are committed to providing holistic care and personalized treatment approaches.

Driven by our passion for innovation and guided by a commitment to excellence, we invest in research and development to bring forward-thinking solutions to the forefront of CNS care. From cutting-edge neuroscience research to the development of targeted therapies and digital health technologies, we are dedicated to advancing the understanding and treatment of neurological and psychiatric disorders.

helcima's CNS portfolio reflects our unwavering dedication to quality, safety, and patient-centered care. By collaborating with leading neurologists, psychiatrists, neuroscientists, and mental health professionals, we aim to develop evidence-based treatments that optimize patient outcomes, reduce disease burden, and promote mental and cognitive well-being.

Join us as we continue to push the boundaries of CNS care, driving innovation, and making a meaningful impact on the lives of patients affected by neurological and psychiatric disorders. Together, let's advance the field of neurology and psychiatry, improve brain health, and empower individuals to live their best lives.